<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Induced pluripotent stem cells offer the possibility to generate patient-specific stem cell lines from individuals affected by inherited disorders </plain></SENT>
<SENT sid="1" pm="."><plain>Cardiomyocytes differentiated from such patient-specific induced pluripotent stem cells lines have been used to study the pathophysiology of arrhythmogenic <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart diseases</z:e>, such as the <z:hpo ids='HP_0001657'>long-QT syndrome</z:hpo> or catecholaminergic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Testing for unwanted drug side effects or tailoring medical treatment to the specific needs of individual patients with arrhythmogenic disorders may become future applications of this emerging technology </plain></SENT>
</text></document>